U.S. Professional Services Stock News

NYSE:HIMS
NYSE:HIMSHealthcare

Is Hims & Hers (HIMS) Using AI Upgrades To Cement A Durable Virtual Care Moat?

Hims & Hers Health recently announced that it would report its first-quarter 2026 results on May 11 and that management would speak at the Evercore TMT Conference, while also outlining platform upgrades, deeper artificial intelligence integration, and expanded partnerships for FDA-approved medications and advanced diagnostic services. By adding AI-enhanced care, multi-cancer early detection testing, and broader access to prescription treatments, the company is pushing further into...
NYSE:ABR
NYSE:ABRMortgage REITs

A Look At Arbor Realty Trust’s Valuation As Earnings Expectations And Cautious Analyst Sentiment Shape The Outlook

Why Arbor Realty Trust (ABR) Is Back on Investors’ Radar Arbor Realty Trust (ABR) is drawing attention after a recent share move ahead of its upcoming earnings report, where analysts are expecting a 42.86% EPS drop and slightly lower revenue. See our latest analysis for Arbor Realty Trust. The recent 1 day share price return of 1.54% and 7 day return of 5.46% suggest traders are positioning ahead of earnings. However, the 1 year total shareholder return decline of 16.52% and flat year to date...
NYSE:CWK
NYSE:CWKReal Estate

Cushman And Wakefield Balances Sotheby’s Lawsuit With New Las Vegas Mandate

Cushman & Wakefield (NYSE:CWK) has filed a lawsuit against Sotheby’s, seeking an alleged unpaid $10 million commission tied to the Weill Cornell real estate transaction. The firm has also been appointed to manage The Ellison, a large multifamily community in Las Vegas. These developments come alongside recent share price levels of $13.89 and a 70.4% return over the past year. For investors watching NYSE:CWK, these moves highlight both legal and operational developments. The commission...
NYSE:VAL
NYSE:VALEnergy Services

Assessing Valaris (VAL) Valuation After Petrobras Extension And New Halliburton PETRONAS Alliance

Why Valaris Stock Is Back in Focus Valaris (VAL) is back on investor radars after two contract announcements: a multiyear extension with Petrobras for the VALARIS DS 4 drillship offshore Brazil, and a new collaboration with Halliburton and PETRONAS Suriname. See our latest analysis for Valaris. Even after the Petrobras extension and new Suriname collaboration, the share price has eased in the last week. However, the 90 day share price return of 67.53% and 1 year total shareholder return of...
NYSE:AI
NYSE:AISoftware

Assessing C3.ai (NYSE:AI) Valuation As Shares Rebound From Recent Weak Performance

Why C3.ai (AI) is back on investor radars C3.ai (AI) has attracted renewed attention after its recent share moves, with the stock showing mixed performance over the past month and over the past three months as investors reassess expectations for this enterprise AI software provider. See our latest analysis for C3.ai. That 13.33% 1 day share price return and 8.43% 7 day share price return come after a much weaker period, with a 30.76% year to date share price decline and a 50.80% 1 year total...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Has Globalstar (GSAT) Run Too Far After 314% One Year Surge?

Wondering if Globalstar's recent share price levels reflect real value or just excitement? This article walks through what the numbers currently say about the stock. Globalstar has seen sharp moves, with returns of 7.6% over the past week, 37.1% over the last 30 days, 26.0% year to date and 314.3% over the past year. Those moves have come as Globalstar continues to feature in coverage around satellite connectivity and its role in broader telecom services. This keeps attention on how its...
NasdaqGM:LARK
NasdaqGM:LARKBanks

Landmark Bancorp (LARK) Net Interest Margin Strengthens To 3.86% Challenging Cautious Earnings Narratives

Landmark Bancorp (LARK) just closed FY 2025 with fourth quarter revenue of US$18.2 million and basic EPS of US$0.78, while trailing twelve month revenue reached US$68.3 million and EPS came in at US$3.09, up from US$58.2 million and US$2.15 a year earlier. Over that same period, trailing twelve month net income moved from US$13.0 million to US$18.8 million. This sets up a results season where investors are likely to focus on how a 27.5% net profit margin shapes views on the bank's earnings...
NYSE:TDC
NYSE:TDCSoftware

Does Teradata’s Azure Analyst Agent With Telemetry Deepen Its AI Moat or Just Extend TDC’s Tools?

Earlier this week, Teradata Corporation announced that its enterprise-grade Analyst Agent is now available on Microsoft Marketplace, enabling AI-assisted conversational analytics directly within customers’ existing Azure and Teradata environments. A distinctive aspect of this launch is Teradata’s Agent Telemetry, which makes the agent’s reasoning observable and auditable, helping enterprises manage AI quality, compliance, and governance more effectively. We’ll now examine how the AI-enabled...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Assessing Flex (FLEX) Valuation After Strong Recent Share Price Momentum

Why Flex (FLEX) may be on your radar today Flex (FLEX) has drawn attention after its recent share performance, with the stock last closing at US$78.43 and showing double digit returns over the past month and past 3 months. See our latest analysis for Flex. Short term momentum has been strong, with a 7 day share price return of 7.16% and a 30 day share price return of 21.69%. The 1 year total shareholder return is also very large, suggesting recent gains sit on top of an already substantial...
NYSE:HIG
NYSE:HIGInsurance

A Look At Hartford Insurance Group’s (HIG) Valuation After Its Recent Shareholder Returns

What Hartford Insurance Group’s recent performance means for shareholders Hartford Insurance Group (HIG) has drawn investor attention after a period of solid share performance, including a past 3 months total return of 6.1% and 1 year total return of 20.4%. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Hartford Insurance Group. At a share price of US$138.75, Hartford’s recent 30 day share price return of 3.0% sits alongside a 1 year total shareholder...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Is It Too Late To Consider Cisco Systems (CSCO) After Its 51% One-Year Surge?

If you are wondering whether Cisco Systems at around US$82.30 is still offering value or if most of the opportunity is already priced in, this article breaks down what the current share price might be implying about the business. The stock has recently shown a mix of short and longer term moves, with a 1.7% decline over the last 7 days, a 4.3% return over 30 days, 8.2% year to date, 51.0% over 1 year, 86.1% over 3 years and 82.8% over 5 years. Recent headlines around Cisco Systems have...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Assessing eBay (EBAY) Valuation After New AI Compliance Efforts And Stricter U.S. Auction Rules

eBay (EBAY) is back in focus after tightening auction rules for U.S. buyers and working with regulators to remove unauthorized medicines, guided by an AI system that has blocked millions of policy violations. See our latest analysis for eBay. Recent product and policy moves, including tighter U.S. auction rules and closer work with regulators on unauthorized medicines, come as eBay’s share price shows a 30 day share price return of 9.41% and a 1 year total shareholder return of 54.91%. If you...
NYSE:MA
NYSE:MADiversified Financial

Is Mastercard (MA) Fairly Priced Today Given Its Premium P/E Multiple And Mixed Recent Returns

Mastercard stock overview With no single headline event driving Mastercard (MA) today, investors are instead weighing the current share price of US$519.96 against the company’s recent returns and its role in global electronic payments. See our latest analysis for Mastercard. The recent 1 day share price return of 1.33% and 7 day share price return of 2.53% sit against a 90 day share price decline of 4.18% and a year to date share price decline of 7.67%. The 1 year total shareholder return of...
NYSE:QGEN
NYSE:QGENLife Sciences

How Investors May Respond To Qiagen (QGEN) Entering Rapid Bloodstream Infection Testing With New Panel

In April 2026, QIAGEN N.V. expanded its QIAstat-Dx syndromic testing platform into bloodstream infections with the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel, which identifies 20 gram-positive bacterial and fungal pathogens and 10 antimicrobial resistance markers from positive blood cultures or colonies in about one hour. This move broadens QIAGEN’s infectious disease portfolio beyond respiratory, gastrointestinal and meningitis/encephalitis testing, aligning its widely deployed...
NYSE:TDG
NYSE:TDGAerospace & Defense

TransDigm’s New US$500m Bond Raises Questions On Debt And M&A Plans

TransDigm Group (NYSE:TDG) has completed a $500 million senior bond offering. The new fixed income issuance is described as supporting liquidity as the company’s financial flexibility grows. The move may be relevant for upcoming corporate actions, such as acquisitions or balance sheet adjustments. TransDigm, a major supplier of aircraft components, tends to attract attention whenever it taps debt markets, because funding decisions can influence future capital allocation. For investors...
NasdaqGS:SAIL
NasdaqGS:SAILSoftware

Assessing SailPoint (SAIL) Valuation After A Mixed Stretch In Recent Share Performance

Recent share performance and what it signals SailPoint (SAIL) has drawn attention after a mixed run in its share price, with a gain of 5.8% over the past day contrasting with negative returns over the week, month, past 3 months and year. See our latest analysis for SailPoint. That 5.8% 1 day share price return stands out against a weaker trend, with the 30 day share price return of 22.02% and year to date share price return of 37.94% pointing to fading momentum from earlier levels. At the...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After New Neurology Data Plans At 2026 AAN Meeting

Jazz Pharmaceuticals (JAZZ) is drawing fresh attention after announcing six scientific presentations at the 2026 American Academy of Neurology meeting, which will feature new clinical data on Epidiolex across epilepsies and Xywav in narcolepsy. See our latest analysis for Jazz Pharmaceuticals. The shares have been firming up, with a 16.46% 90 day share price return and a 96.29% 1 year total shareholder return. This suggests recent enthusiasm is building around the pipeline news and broader...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

A Look At Rigetti Computing (RGTI) Valuation After Cepheus-1-108Q Launch And Major India Contract

Rigetti Computing (RGTI) is back in focus after launching its 108-qubit Cepheus-1-108Q system and landing a US$8.4 million contract with India’s Centre for Development of Advanced Computing, raising fresh questions about risk and reward. See our latest analysis for Rigetti Computing. The launch of Cepheus-1-108Q and the India contract have coincided with a sharp shift in sentiment, with Rigetti’s 7 day share price return of 31.52% and 1 day gain of 13.28% standing out against a year to date...
NYSE:QSR
NYSE:QSRHospitality

Popeyes One Piece Tie Up Tests Restaurant Brands International’s Gen Z Reach

Popeyes, part of Restaurant Brands International, has launched its first anime collaboration with Toei Animation's "One Piece". The tie up introduces a themed menu, limited time items, co branded merchandise, and a promotional giveaway. The campaign is designed to connect with Gen Z and anime fans and is positioned as a consumer engagement push for the brand. For investors watching Restaurant Brands International, ticker NYSE:QSR, this move comes alongside recent share performance and an...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) Valuation Check As Board Restructuring And Leadership Changes Take Shape

Henry Schein (HSIC) has drawn fresh attention after announcing a planned reduction in its Board of Directors in 2026, including the retirement of long-serving director Stanley M. Bergman after 44 years. See our latest analysis for Henry Schein. The recent Board changes come after a year where Henry Schein delivered a 22.33% total shareholder return, while the 3 year total shareholder return of a 6.67% decline and 5 year total shareholder return of 7.08% show more muted progress. This suggests...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Is Ulta’s Messi Fragrances And Virtue Labs Push Altering The Investment Case For Ulta Beauty (ULTA)?

In early April 2026, Virtue Labs announced a major expansion of its partnership with Ulta Beauty, adding the haircare brand to more than 230 additional stores and rolling out new in-line installations, while Sheralven Enterprises revealed plans for Messi Fragrances to launch exclusively across all Ulta Beauty stores and Ulta Beauty Mexico from May 17, 2026. Together, these moves underscore how Ulta’s physical footprint and omni-channel reach are becoming a launchpad for emerging haircare...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

ARK Invest Buying Puts Spotlight On Palantir’s Expensive AI Valuation

Cathie Wood's ARK Invest reportedly bought about US$11m of Palantir Technologies (NasdaqGS:PLTR) shares through its ETFs. Other institutional investors are also adding to positions, reflecting renewed interest in Palantir's enterprise AI offering. The buying comes as debate intensifies over Palantir's defensibility against enterprise AI challenger Anthropic. Public endorsements, including from former President Trump, are keeping Palantir in the spotlight alongside these capital...
NYSE:C
NYSE:CBanks

Citigroup (C) Cost Efficiency Gains Reinforce Bullish Earnings Narratives In Q1 2026

Citigroup (C) opened 2026 with Q1 revenue of US$22.1b and basic EPS of US$3.31, set against trailing twelve month revenue of US$78.7b and EPS of US$8.44 that has been growing at about 21.2% year over year. Over the past year, the bank has seen revenue move from US$71.0b to US$78.7b and net income from US$11.5b to US$14.7b. EPS rose from US$6.03 to US$8.44, giving investors a cleaner read on earnings momentum. With net profit margins reported at 18.7% and a 1.82% dividend yield, the latest...